Lipid nanoparticles for parenteral delivery of actives

被引：337

作者：

Joshi, Medha D. ^{[1
]}

Mueller, Rainer H. ^{[1
]}

机构：

[1] Free Univ Berlin, Dept Pharmaceut Technol Biopharmaceut & NutriCosm, D-12169 Berlin, Germany

来源：

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 2009年 / 71卷 / 02期

关键词：

Lipid nanoparticles; Solid lipid nanoparticles (SLN); Nanostructured lipid carriers (NLC); Lipid drug conjugates (LDC); Parenteral delivery; PROTEIN ADSORPTION PATTERNS; 80-COATED POLYBUTYLCYANOACRYLATE NANOPARTICLES; BLOOD-BRAIN-BARRIER; BREAST-CANCER CELLS; TUMOR-BEARING MICE; IN-VITRO; TISSUE DISTRIBUTION; DRUG-DELIVERY; CYTOKINE PRODUCTION; PHARMACOKINETIC EVALUATION;

D O I：

10.1016/j.ejpb.2008.09.003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The present review compiles the applications of lipid nanoparticles mainly solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) and lipid drug conjugates (LDC) in parenteral delivery of pharmaceutical actives. The attempts to incorporate anticancer agents, imaging agents, antiparasitics, antiarthritics, genes for transfection, agents for liver, cardiovascular and central nervous system targeting have been summarized. The utility of lipid nanoparticles as adjuvant has been discussed separately. A special focus of this review is on toxicity caused by these kinds of lipid nanoparticles with a glance on the fate of lipid nanoparticles after their parenteral delivery in vivo viz the protein adsorption patterns. (C) 2008 Elsevier B.V. All rights reserved.

引用

页码：161 / 172

页数：12

共 140 条

[1]

ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173

[2] Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles [J].

Alyautdin, RN ;

Petrov, VE ;

Langer, K ;

Berthold, A ;

Kharkevich, DA ;

Kreuter, J .

PHARMACEUTICAL RESEARCH, 1997, 14 (03) :325-328

[3] Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study [J].

Alyautdin, RN ;

Tezikov, EB ;

Ramge, P ;

Kharkevich, DA ;

Begley, DJ ;

Kreuter, J .

JOURNAL OF MICROENCAPSULATION, 1998, 15 (01) :67-74

[4] Diclofenac sodium delivery to the eye:: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct [J].

Attama, Anthony A. ;

Reichl, Stephan ;

Mueller-Goymann, Christel C. .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 355 (1-2) :307-313

[5] Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats [J].

Bargoni, A ;

Cavalli, R ;

Caputo, O ;

Fundarò, A ;

Gasco, MR ;

Zara, GP .

PHARMACEUTICAL RESEARCH, 1998, 15 (05) :745-750

[6] Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats.: Part II -: Tissue distribution [J].

Bargoni, A ;

Cavalli, R ;

Zara, GP ;

Fundarò, A ;

Caputo, O ;

Gasco, MR .

PHARMACOLOGICAL RESEARCH, 2001, 43 (05) :497-502

[7] Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery [J].

Bondi, Maria Luisa ;

Azzolina, Antonina ;

Craparo, Emanuela Fabiola ;

Lampiasi, Nadia ;

Capuano, Giulia ;

Giammona, Gaetano ;

Cervello, Melchiorre .

JOURNAL OF DRUG TARGETING, 2007, 15 (04) :295-301

[8] Nanostructured lipid carriers-containing anticancer compounds: Preparation, characterization, and cytotoxicity studies [J].

Bondi, Maria Luisa ;

Craparo, Emanuela Fabiola ;

Giammona, Gaetano ;

Cervello, Melchiorre ;

Azzolina, Antonina ;

Diana, Patrizia ;

Martorana, Anna ;

Cirrincione, Girolatno .

DRUG DELIVERY, 2007, 14 (02) :61-67

[9] Preparation and characterization of solid lipid nanoparticles containing cloricromene [J].

Bondì, ML ;

Fontana, G ;

Carlisi, B ;

Giammona, G .

DRUG DELIVERY, 2003, 10 (04) :245-250

[10]

Bunjes H, 2007, NANOPARTICULATE DRUG, P213

← 1 2 3 4 5 6 7 8 9 10 →